Suppr超能文献

肝移植的当前适应证和禁忌证。

Current indications and contraindications for liver transplantation.

作者信息

Ahmed Aijaz, Keeffe Emmet B

机构信息

Division of Gastroenterology and Hepatology, Liver Transplant Program, Stanford University School of Medicine, Stanford, CA 94304, USA.

出版信息

Clin Liver Dis. 2007 May;11(2):227-47. doi: 10.1016/j.cld.2007.04.008.

Abstract

Survival rates after liver transplantation have improved steadily because of earlier referral and timely evaluation, judicious patient selection, improved surgical techniques, superior immunosuppressive regimens, and effective prevention of perioperative opportunistic infections. Indications and contraindications for liver transplantation are undergoing constant modifications with the goal of improving survival and functional status of patients who have end-stage liver disease or acute liver failure. Potential candidates for liver transplantation should meet minimal listing criteria and not have contraindications to liver transplantation. Currently, the Model for End-stage Liver Disease score is used for organ allocation, but it may have future application in patient-selection criteria.

摘要

由于更早的转诊和及时的评估、明智的患者选择、改进的手术技术、更优的免疫抑制方案以及围手术期机会性感染的有效预防,肝移植后的生存率稳步提高。肝移植的适应证和禁忌证正在不断调整,目的是提高终末期肝病或急性肝衰竭患者的生存率和功能状态。肝移植的潜在候选人应符合最低列入标准,且没有肝移植的禁忌证。目前,终末期肝病模型评分用于器官分配,但它可能在未来用于患者选择标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验